相关实验视频

Updated: May 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

开发和验证基于血小板指数的结肠直肠癌生存预后诺莫格拉姆的开发和验证

Erwin Syarifuddin¹, Warsinggih Raharjo¹, Rina Masadah²

¹Division of Digestive Surgery, Department of Surgery, Hasanuddin University, Makassar, Indonesia.

Asian Pacific journal of cancer prevention : APJCP

|April 30, 2025

概括

一种新型的血小板指数纳入的诺姆图准确地预测了印度尼西亚结直肠癌 (CRC) 患者的生存率. 这个工具有助于治疗规划和患者沟通关于CRC存活率.

科学领域:

在瘤学瘤学.
生物统计学生物统计学
医疗信息学医疗信息学

背景情况:

预后模型对于结直肠癌 (CRC) 治疗计划和患者沟通至关重要.
血小板指数正在成为癌症的显著预后标志物.

研究的目的:

开发和验证用于预测印尼CRC患者的生存结果的诺米克图.
将血小板指数整合到CRC的预后模型中.

主要方法:

对CRC患者的前性队列研究 (2019-2024年).
数据包括人口统计,临床因素和血小板指数.
考克斯回归和R包 ("rms", "生存") 用于名录的开发和验证.

主要成果:

包括血小板指数在内的13个因素显著影响了CRC存活率.
开发的名图表显示出高的预测准确性 (C指数在培训中为0.90,在验证中为0.91).

结论:

成功地为印尼CRC患者创建了一个验证的预后诺姆图.
诺米图有效地预测CRC生存概率,帮助临床决策.

关键词:

结直肠直肠直肠直肠直肠直肠这个名字是名ogramogram.幸存率幸存率生存率

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...